Cue Biopharma

(NASDAQ) CUE

Current Price$19.00

Market Cap$82.65M

Since IPO (2018)-94%

5 Year-95%

1 Year+2%

1 Month-20%

Cue Biopharma Financials at a Glance

Market Cap

$82.65M

Revenue (TTM)

$32.73M

Net Income (TTM)

$19.52M

EPS (TTM)

$-5.53

P/E Ratio

-3.70

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$19.00

Volume

3,767

Open

$19.47

Price

$19.00

Volume

3,767

Open

$19.47

Previous Close

$20.43

Daily Range

$18.35 - $19.47

52-Week Range

$4.97 - $41.42

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$19.00

Volume

3,767

Open

$19.47

Previous Close

$20.43

Daily Range

$18.35 - $19.47

52-Week Range

$4.97 - $41.42

CUE News

3 Biotech Start-Ups That Could Soar in 2020

Cory RenauerJan 27, 2020

3 Growth Stocks That Could Put Netflix's Returns to Shame

Anders BylundApr 20, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cue Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Usman Azam, MD

Website

www.cuebiopharma.com

Headquarters

Boston, MA 02139, US

CUE Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-60%

Net Income Margin

-60%

Return on Equity

-139%

Return on Capital

-83%

Return on Assets

-63%

Earnings Yield

-27.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$82.65M

Shares Outstanding

4.05M

Volume

3.77K

Avg. Volume

754.07K

Financials (TTM)

Gross Profit

$27.47M

Operating Income

$26.52M

EBITDA

$22.27M

Operating Cash Flow

$21.69M

Capital Expenditure

$177.00K

Free Cash Flow

$21.86M

Cash & ST Invst.

$27.14M

Total Debt

$4.20M

Cue Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$5.69M

+1250.6%

Gross Profit

$5.69M

+1250.6%

Gross Margin

100.00%

N/A

Market Cap

$82.65M

N/A

Market Cap/Employee

$2.02M

N/A

Employees

N/A

Net Income

$5.18M

+57.8%

EBITDA

$4.25M

+62.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$12.94M

+115.3%

Accounts Receivable

$5.35M

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.88M

+967.0%

Short Term Debt

$1.56M

-77.5%

Return on Assets

-63.23%

N/A

Return on Invested Capital

-83.39%

N/A

Free Cash Flow

$11.06M

-32.9%

Operating Cash Flow

$10.94M

-33.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EQEquillium, Inc.

EQEquillium, Inc.$2.13+3.40%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$51.04-0.92%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$3.05+2.69%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.68-0.44%

SNTISenti Biosciences, Inc.

SNTISenti Biosciences, Inc.$1.00+1.66%

OTLKOutlook Therapeutics, Inc.

OTLKOutlook Therapeutics, Inc.$0.30+8.10%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.74+0.00%

TET1 Energy Inc.

TET1 Energy Inc.$9.20+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.69-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.66+0.01%

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF$6.05-0.51%

APLDApplied Digital

APLDApplied Digital$47.17+0.19%

RGTIRigetti Computing

RGTIRigetti Computing$21.35+0.26%

Questions About CUE

What is the current price of Cue Biopharma?

Cue Biopharma is trading at $19.00 per share.

What is the 52-week range for Cue Biopharma?

Over the past 52 weeks, Cue Biopharma has traded between $4.97 and $41.42.

How much debt does Cue Biopharma have?

As of the most recent reporting period, Cue Biopharma reported total debt of $3.44M.

How much cash does Cue Biopharma have on hand?

Cue Biopharma reported $16.38M in cash and cash equivalents in its most recent financial results.

What is Cue Biopharma’s dividend yield?

Cue Biopharma does not currently have a dividend yield.

Cue Biopharma

Cue Biopharma Financials at a Glance

CUE News

3 Biotech Start-Ups That Could Soar in 2020

3 Growth Stocks That Could Put Netflix's Returns to Shame

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cue Biopharma

CUE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cue Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CUE

What is the current price of Cue Biopharma?

What is the 52-week range for Cue Biopharma?

How much debt does Cue Biopharma have?

How much cash does Cue Biopharma have on hand?

What is Cue Biopharma’s dividend yield?

Premium Investing Services